Studies related to Depression and Agmatine

The clinical antidepressant effect of exogenous agmatine is not reversed by parachlorophenylalanine: a pilot study
Effect Decrease
Trial Design Non-controlled trial
Trial Length 1-6 months
Number of Subjects 3
Sex Both Genders
Age Range 18-29, 30-44, 45-64
Notes for this study:
Oral ingestion of 2-3 g agmatine over 6-8 weeks in three subjects who were diagnosed with either major depressive disorder or unipolar depression, who were not on any pharmaceuticals nor did they have treatment-resistant depression, was able to induce remission of depressive symptoms in all subjects.